vildagliptina/metformina almus 50 mg/850 mg comprimidos recubiertos con pelicula efg
almus farmaceutica s.a.u. - vildagliptina; metformina hidrocloruro - comprimido recubierto con pelÍcula - 50 mg/850 mg - vildagliptina 50 mg; metformina hidrocloruro 850 mg - metformina y vildagliptina
trandolapril arrow 4 mg capsulas efg
arrow generics limited - trandolapril - excipientes: lactosa monohidrato,almidon de maiz,croscarmelosa sodica,fumarato de estearilo y sodio,alcohol etilico (etanol),propilenglicol,potasio, hidroxido de - inhibidores de la eca, monofÁrmacos - inhibidores de la eca, monofármacos - trandolapril
trandolapril arrow 0,5 mg capsulas efg
arrow generics limited - trandolapril - excipientes: lactosa monohidrato,almidon de maiz,croscarmelosa sodica,fumarato de estearilo y sodio,alcohol etilico (etanol),propilenglicol,potasio, hidroxido de - inhibidores de la eca, monofÁrmacos - inhibidores de la eca, monofármacos - trandolapril
trandolapril arrow 2 mg capsulas efg
arrow generics limited - trandolapril - excipientes: lactosa monohidrato,almidon de maiz,croscarmelosa sodica,fumarato de estearilo y sodio,rojo allura ac (e129),alcohol etilico (etanol),propilenglicol,potasio, hidroxido de,rojo allura ac (e129) - inhibidores de la eca, monofÁrmacos - inhibidores de la eca, monofármacos - trandolapril
vildagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, tipo 2 - drogas usadas en diabetes - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 y 5. 1 para datos disponibles sobre diferentes combinaciones).
vildagliptina/metformina stada 50 mg/1000 mg comprimidos recubiertos con pelicula efg
laboratorio stada s.l. - metformina hidrocloruro; vildagliptina - comprimido recubierto con pelÍcula - 50 mg/1000 mg - metformina hidrocloruro 1000 mg; vildagliptina 50 mg - metformina y vildagliptina
vildagliptina/metformina stada 50 mg/850 mg comprimidos recubiertos con pelicula efg
laboratorio stada s.l. - metformina hidrocloruro; vildagliptina - comprimido recubierto con pelÍcula - 50 mg/850 mg - metformina hidrocloruro 850 mg; vildagliptina 50 mg - metformina y vildagliptina
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - vildagliptina, metformin hidrocloruro - diabetes mellitus, tipo 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 y 5. 1 para datos disponibles sobre diferentes combinaciones).
tarka 180 mg/ 2 mg capsulas de liberacion modificada
mylan ire healthcare limited - trandolapril; verapamilo hidrocloruro - cÁpsula dura de liberaciÓn prolongada - 2 mg/180 mg - trandolapril 2 mg; verapamilo hidrocloruro 180 mg - trandolapril y verapamilo
gopten 0,5 mg capsulas duras
mylan ire healthcare limited - trandolapril - cÁpsula dura - 0,5 mg - trandolapril 0,5 mg - trandolapril